Hailin Tang Selected Research

Hailin Tang Research Topics

Disease

77	Neoplasms (Cancer) 01/2022 - 04/2010
62	Breast Neoplasms (Breast Cancer) 03/2022 - 01/2013
30	Neoplasm Metastasis (Metastasis) 03/2022 - 01/2013
28	Triple Negative Breast Neoplasms 01/2022 - 01/2014
21	Carcinogenesis 01/2022 - 09/2011
13	Glioma (Gliomas) 12/2019 - 05/2011
6	Nasopharyngeal Carcinoma 06/2013 - 04/2010
5	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 06/2011
4	Stomach Neoplasms (Stomach Cancer) 02/2021 - 10/2013
3	Infections 10/2022 - 01/2020
3	Inflammation (Inflammations) 01/2021 - 01/2012
3	Lymphatic Metastasis 01/2020 - 01/2018
2	COVID-19 10/2022 - 01/2022
2	Neuroblastoma 10/2022 - 01/2017
2	Uveal melanoma 05/2016 - 01/2015
1	West Nile Fever 10/2022
1	Weight Loss (Weight Reduction) 10/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Colitis 01/2022
1	Experimental Arthritis 01/2022
1	Lung Neoplasms (Lung Cancer) 12/2021
1	Necrosis 12/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021
1	Liver Neoplasms (Liver Cancer) 04/2021
1	Interstitial Cystitis (Interstitial Cystitis, Chronic) 01/2021

Drug/Important Bio-Agent (IBA)

30	Biomarkers (Surrogate Marker)IBA 06/2021 - 05/2011
24	MicroRNAs (MicroRNA)IBA 01/2021 - 04/2010
18	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2011
12	Circular RNAIBA 01/2022 - 10/2017
11	Biological ProductsIBA 01/2022 - 05/2012
8	CateninsIBA 03/2022 - 10/2015
8	Long Noncoding RNAIBA 03/2020 - 01/2018
7	RNA (Ribonucleic Acid)IBA 12/2021 - 08/2012
7	Pharmaceutical PreparationsIBA 09/2021 - 04/2015
7	Messenger RNA (mRNA)IBA 06/2020 - 01/2013
5	Competitive Endogenous RNAIBA 04/2021 - 01/2018
5	isoliquiritigenin (GU 17)IBA 01/2021 - 01/2015
4	diallyl disulfide (diallyl disulphide)IBA 02/2021 - 10/2013
4	Indicators and Reagents (Reagents)IBA 03/2020 - 04/2015
4	AntigensIBA 01/2019 - 01/2016
3	Antiviral Agents (Antivirals)IBA 10/2022 - 01/2020
3	IronIBA 01/2022 - 12/2021
3	Fluorouracil (Carac)FDA LinkGeneric 01/2020 - 01/2014
3	Carcinoembryonic AntigenIBA 10/2018 - 01/2016
3	Oncogene Proteins (Oncogene Protein)IBA 04/2018 - 03/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 02/2016
3	LipidsIBA 04/2017 - 01/2015
3	Lactate Dehydrogenase 5IBA 01/2017 - 02/2016
2	Ellagic AcidIBA 03/2022 - 12/2017
2	CurcuminIBA 03/2022 - 10/2013
2	Emodin (Archin)IBA 03/2022 - 10/2013
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 03/2020 - 03/2020
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 01/2016
2	AnthracyclinesIBA 01/2020 - 01/2015
2	Therapeutic UsesIBA 01/2020 - 01/2014
2	LuciferasesIBA 12/2019 - 01/2014
2	Endoplasmic Reticulum Chaperone BiPIBA 01/2018 - 01/2018
2	MethyltransferasesIBA 01/2018 - 09/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 09/2011
2	GoldIBA 10/2017 - 12/2016
2	HDL CholesterolIBA 04/2017 - 01/2016
2	Triglycerides (Triacylglycerol)IBA 04/2017 - 01/2016
2	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2017 - 01/2015
2	Paclitaxel (Taxol)FDA LinkGeneric 08/2015 - 01/2013
2	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2015 - 07/2014
2	Liposomes (Liposome)IBA 01/2015 - 07/2014
2	Conditioned Culture MediaIBA 08/2013 - 01/2012
2	hydrogen sulfite (bisulfite)IBA 05/2012 - 05/2011
1	vidofludimusIBA 10/2022
1	teriflunomideIBA 10/2022
1	bazedoxifeneIBA 10/2022
1	Dihydroorotate DehydrogenaseIBA 10/2022
1	Selective Estrogen Receptor Modulators (SERM)IBA 10/2022
1	Tamoxifen FDA LinkGeneric 10/2022
1	cilnidipineIBA 10/2022
1	Clomiphene (Clomifene)FDA LinkGeneric 10/2022
1	Interleukin-6 (Interleukin 6)IBA 10/2022
1	Toremifene (Fareston)FDA Link 10/2022
1	nitazoxanide (NTZ)FDA Link 10/2022
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 10/2022
1	afadinIBA 01/2022
1	gilteritinibIBA 01/2022
1	Dextrans (Dextran)FDA Link 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	remdesivirIBA 01/2022
1	Sertraline (Zoloft)FDA LinkGeneric 01/2022
1	inerminIBA 01/2022
1	salinomycinIBA 01/2022
1	MXeneIBA 01/2022
1	N-methyladenosineIBA 01/2022
1	SodiumIBA 01/2022
1	A 19IBA 12/2021
1	Glutathione (Reduced Glutathione)IBA 09/2021
1	PlatinumIBA 09/2021

Therapy/Procedure

30	Therapeutics 10/2022 - 05/2011
6	Drug Therapy (Chemotherapy) 01/2020 - 02/2013
3	Immunotherapy 01/2021 - 01/2017
2	Neoadjuvant Therapy 09/2021 - 01/2018
2	Mastectomy (Mammectomy) 01/2020 - 01/2020
2	Microspheres (Microsphere) 10/2017 - 12/2016